首页 > 最新文献

Current Problems in Cardiology最新文献

英文 中文
Ongoing and future clinical trials of device therapies for patients with heart failure 针对心力衰竭患者的设备疗法正在进行的和未来的临床试验。
IF 3 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-08-17 DOI: 10.1016/j.cpcardiol.2024.102805

Heart failure continues to pose a significant burden in terms of morbidity, mortality, and healthcare costs worldwide despite the implementation of guideline-directed medical therapy. Addressing this challenge and improving clinical outcomes for this patient population remains an urgent priority. Recognizing the limitations in current medical approaches and exploring strategies to overcome these limitations are crucial steps toward improving future outcomes. Various device-based interventions, such as Cardiac Resynchronization Therapy devices and Left Ventricular Assist Devices, have demonstrated notable benefits for individuals with heart failure. Our review is aimed at summarizing the ongoing research into new device therapies for heart failure, emphasizing their potential to overcome the current challenges in treatment. By utilizing Clinicaltrials.gov, an online repository, we conducted a comprehensive search for trials investigating emerging device therapies for patients dealing with heart failure.

尽管实施了指南指导下的医疗治疗,但心力衰竭仍在发病率、死亡率和医疗成本方面给全世界造成了沉重负担。应对这一挑战并改善这一患者群体的临床治疗效果仍是当务之急。认识到当前医疗方法的局限性并探索克服这些局限性的策略,是改善未来治疗效果的关键步骤。各种基于设备的干预措施,如心脏再同步化治疗设备和左心室辅助设备,已为心力衰竭患者带来显著疗效。我们的综述旨在总结正在进行的心力衰竭新设备疗法研究,强调其克服当前治疗难题的潜力。我们利用在线资料库 Clinicaltrials.gov,全面搜索了针对心衰患者的新兴设备疗法的研究试验。
{"title":"Ongoing and future clinical trials of device therapies for patients with heart failure","authors":"","doi":"10.1016/j.cpcardiol.2024.102805","DOIUrl":"10.1016/j.cpcardiol.2024.102805","url":null,"abstract":"<div><p>Heart failure continues to pose a significant burden in terms of morbidity, mortality, and healthcare costs worldwide despite the implementation of guideline-directed medical therapy. Addressing this challenge and improving clinical outcomes for this patient population remains an urgent priority. Recognizing the limitations in current medical approaches and exploring strategies to overcome these limitations are crucial steps toward improving future outcomes. Various device-based interventions, such as Cardiac Resynchronization Therapy devices and Left Ventricular Assist Devices, have demonstrated notable benefits for individuals with heart failure. Our review is aimed at summarizing the ongoing research into new device therapies for heart failure, emphasizing their potential to overcome the current challenges in treatment. By utilizing Clinicaltrials.gov, an online repository, we conducted a comprehensive search for trials investigating emerging device therapies for patients dealing with heart failure.</p></div>","PeriodicalId":51006,"journal":{"name":"Current Problems in Cardiology","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142005787","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating ChatGPT platform in delivering heart failure educational material: A comparison with the leading national cardiology institutes 评估 ChatGPT 平台在提供心力衰竭教育材料方面的作用:与主要国家心脏病研究所的比较。
IF 3 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-08-17 DOI: 10.1016/j.cpcardiol.2024.102797

Background

Patient education plays a crucial role in improving the quality of life for patients with heart failure. As artificial intelligence continues to advance, new chatbots are emerging as valuable tools across various aspects of life. One prominent example is ChatGPT, a widely used chatbot among the public. Our study aims to evaluate the readability of ChatGPT answers for common patients’ questions about heart failure.

Methods

We performed a comparative analysis between ChatGPT responses and existing heart failure educational materials from top US cardiology institutes. Validated readability calculators were employed to assess and compare the reading difficulty and grade level of the materials. Furthermore, blind assessment using The Patient Education Materials Assessment Tool (PEMAT) was done by four advanced heart failure attendings to evaluate the readability and actionability of each resource.

Results

Our study revealed that responses generated by ChatGPT were longer and more challenging to read compared to other materials. Additionally, these responses were written at a higher educational level (undergraduate and 9-10th grade), similar to those from the Heart Failure Society of America. Despite achieving a competitive PEMAT readability score (75 %), surpassing the American Heart Association score (68 %), ChatGPT's actionability score was the lowest (66.7 %) among all materials included in our study.

Conclusion

Despite its current limitations, artificial intelligence chatbots has the potential to revolutionize the field of patient education especially given theirs ongoing improvements. However, further research is necessary to ensure the integrity and reliability of these chatbots before endorsing them as reliable resources for patient education.

背景:患者教育对提高心衰患者的生活质量起着至关重要的作用。随着人工智能的不断进步,新的聊天机器人正在成为生活各方面的重要工具。其中一个突出的例子就是在公众中广泛使用的聊天机器人 ChatGPT。我们的研究旨在评估 ChatGPT 在回答患者有关心衰的常见问题时的可读性:我们对 ChatGPT 的回答与美国顶级心脏病学机构现有的心衰教育材料进行了对比分析。我们使用了经过验证的可读性计算器来评估和比较材料的阅读难度和级别。此外,四名高级心力衰竭主治医师使用患者教育材料评估工具(PEMAT)进行了盲评,以评估每种资源的可读性和可操作性:我们的研究显示,与其他材料相比,ChatGPT 生成的回复更长,更难阅读。此外,这些回复的教育程度较高(本科和 9-10 年级),与美国心力衰竭协会的回复相似。尽管 ChatGPT 的 PEMAT 可读性得分(75%)很有竞争力,超过了美国心脏协会的得分(68%),但它的可操作性得分(66.7%)却是所有研究材料中最低的:尽管人工智能聊天机器人目前还存在一些局限性,但它有可能在患者教育领域掀起一场革命,尤其是考虑到其正在不断改进。然而,有必要开展进一步研究,以确保这些聊天机器人的完整性和可靠性,然后再将其认可为可靠的患者教育资源。
{"title":"Evaluating ChatGPT platform in delivering heart failure educational material: A comparison with the leading national cardiology institutes","authors":"","doi":"10.1016/j.cpcardiol.2024.102797","DOIUrl":"10.1016/j.cpcardiol.2024.102797","url":null,"abstract":"<div><h3>Background</h3><p>Patient education plays a crucial role in improving the quality of life for patients with heart failure. As artificial intelligence continues to advance, new chatbots are emerging as valuable tools across various aspects of life. One prominent example is ChatGPT, a widely used chatbot among the public. Our study aims to evaluate the readability of ChatGPT answers for common patients’ questions about heart failure.</p></div><div><h3>Methods</h3><p>We performed a comparative analysis between ChatGPT responses and existing heart failure educational materials from top US cardiology institutes. Validated readability calculators were employed to assess and compare the reading difficulty and grade level of the materials. Furthermore, blind assessment using The Patient Education Materials Assessment Tool (PEMAT) was done by four advanced heart failure attendings to evaluate the readability and actionability of each resource.</p></div><div><h3>Results</h3><p>Our study revealed that responses generated by ChatGPT were longer and more challenging to read compared to other materials. Additionally, these responses were written at a higher educational level (undergraduate and 9-10th grade), similar to those from the Heart Failure Society of America. Despite achieving a competitive PEMAT readability score (75 %), surpassing the American Heart Association score (68 %), ChatGPT's actionability score was the lowest (66.7 %) among all materials included in our study.</p></div><div><h3>Conclusion</h3><p>Despite its current limitations, artificial intelligence chatbots has the potential to revolutionize the field of patient education especially given theirs ongoing improvements. However, further research is necessary to ensure the integrity and reliability of these chatbots before endorsing them as reliable resources for patient education.</p></div>","PeriodicalId":51006,"journal":{"name":"Current Problems in Cardiology","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142005786","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to “Timing of coronary artery bypass grafting after myocardial infarction influences late survival” 对 "心肌梗死后冠状动脉旁路移植术的时机影响晚期存活率 "的回应
IF 3 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-08-17 DOI: 10.1016/j.cpcardiol.2024.102803
{"title":"Response to “Timing of coronary artery bypass grafting after myocardial infarction influences late survival”","authors":"","doi":"10.1016/j.cpcardiol.2024.102803","DOIUrl":"10.1016/j.cpcardiol.2024.102803","url":null,"abstract":"","PeriodicalId":51006,"journal":{"name":"Current Problems in Cardiology","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142005788","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of self-management education on clinical outcomes of adults with rheumatic heart disease: A quasi-experimental study 自我管理教育对成人风湿性心脏病患者临床疗效的影响:一项准实验研究。
IF 3 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-08-17 DOI: 10.1016/j.cpcardiol.2024.102796

As the burden of rheumatic heart disease (RHD) increases in Ethiopia, there is a growing need for low-cost interventions to mitigate its impact. This study aimed to assess the effectiveness of chronic disease self-management education (CDSME) on clinical outcomes, depression, and anxiety among patients with RHD. A quasi-experimental study was deployed among 166 patients with RHD at Jimma Medical Center between April and July 2024. A multi-component CDSME was endured for four consecutive months. Data were analyzed using SPSS version 25.0. Systolic blood pressure decreased from 131.31 mmHg (SD±15.68) at pre-education to 113.77 mmHg (SD±20.98) at post-education (t- 12.251, p<0.001). Diastolic blood pressure decreased from 94.87 mmHg (SD±19.41) pre-education to 79.28 mmHg (SD±9.33) post-education (t-12.306, p<0.001). Hemoglobin level changed from 11.97 g/dl (SD±1.99) to 13.84 g/dl (SD±1.37) after the intervention (t -11.96, p < 0.001). Similarly, hospital depression subscale decreased from 11.93 (SD±3.43) to 9.48 (SD±3.67) (t - 8.37, p < 0.001) post intervention. Regarding the hospital anxiety subscale, the mean score before education program was 8.59 (SD±2.91) and decreased to 7.30 (SD±1.97) (t -6.44, p < 0.001) after education. This intervention is simple, cost-effective, and has the potential to be scaled up and implemented in the current healthcare system in Ethiopia.

随着埃塞俄比亚风湿性心脏病(RHD)负担的加重,人们越来越需要低成本的干预措施来减轻其影响。本研究旨在评估慢性病自我管理教育(CDSME)对风湿性心脏病患者临床疗效、抑郁和焦虑的影响。2024 年 4 月至 7 月期间,在吉马医疗中心对 166 名急性膀胱炎患者进行了一项准实验研究。在连续四个月的时间里,患者接受了多成分 CDSME 治疗。数据使用 SPSS 25.0 版进行分析。收缩压从教育前的 131.31 mmHg(SD±15.68)下降到教育后的 113.77 mmHg(SD±20.98)(t- 12.251, p
{"title":"Effects of self-management education on clinical outcomes of adults with rheumatic heart disease: A quasi-experimental study","authors":"","doi":"10.1016/j.cpcardiol.2024.102796","DOIUrl":"10.1016/j.cpcardiol.2024.102796","url":null,"abstract":"<div><p>As the burden of rheumatic heart disease (RHD) increases in Ethiopia, there is a growing need for low-cost interventions to mitigate its impact. This study aimed to assess the effectiveness of chronic disease self-management education (CDSME) on clinical outcomes, depression, and anxiety among patients with RHD. A quasi-experimental study was deployed among 166 patients with RHD at Jimma Medical Center between April and July 2024. A multi-component CDSME was endured for four consecutive months. Data were analyzed using SPSS version 25.0. Systolic blood pressure decreased from 131.31 mmHg (SD±15.68) at pre-education to 113.77 mmHg (SD±20.98) at post-education (t- 12.251, p&lt;0.001). Diastolic blood pressure decreased from 94.87 mmHg (SD±19.41) pre-education to 79.28 mmHg (SD±9.33) post-education (t-12.306, p&lt;0.001). Hemoglobin level changed from 11.97 g/dl (SD±1.99) to 13.84 g/dl (SD±1.37) after the intervention (t -11.96, p &lt; 0.001). Similarly, hospital depression subscale decreased from 11.93 (SD±3.43) to 9.48 (SD±3.67) (t - 8.37, p &lt; 0.001) post intervention. Regarding the hospital anxiety subscale, the mean score before education program was 8.59 (SD±2.91) and decreased to 7.30 (SD±1.97) (t -6.44, p &lt; 0.001) after education. This intervention is simple, cost-effective, and has the potential to be scaled up and implemented in the current healthcare system in Ethiopia.</p></div>","PeriodicalId":51006,"journal":{"name":"Current Problems in Cardiology","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142005785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictors of arrhythmias in the population hospitalized for SARS-CoV-2 因 SARS-CoV-2 而住院的人群中心律失常的预测因素
IF 3 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-08-11 DOI: 10.1016/j.cpcardiol.2024.102792

Background

Studies exploring predictors of arrhythmias in the population primarily hospitalized for SARS-CoV-2 (COVID-19) are scarce. Understanding this is crucial for risk stratification and appropriate management.

Methods

Using the 2020 National Inpatient Sample (NIS) database, we identified primary admissions for COVID-19. A ‘greedy neighbor’ 1:1 propensity-score matching (PSM) accounted for baseline differences. Then, multivariable logistic regression models were employed to account for confounders and estimate the probability of arrhythmia.

Results

There were a total of 1,058,815 admissions for COVID-19 (mean age 64.3 years ±16.8), 47.2% female, 52.5% (107698) White, 18.5% (37973) Blacks, and 20.7% (42,447) Hispanics. Atrial fibrillation was the most prevalent arrhythmia, 15.1% (31,942). After PSM, 166,405 arrhythmia hospitalizations were matched to 166,405 hospitalizations without arrhythmia. Sick sinus syndrome 4.9 (4.4-5.5), dyslipidemia 1.2 (1.2–1.3), cardiac arrest 1.3 (1.1-1.4), invasive mechanical ventilation 1.9 (1.8-2.0) and obesity 1.3 (1.2-1.4), (p<0.0001, all) were all independent predictors of arrhythmias.

Conclusions

Our analysis revealed a notable proportion of hospitalized COVID-19 patients with arrhythmias. Dyslipidemia, obesity, sick sinus syndrome, invasive mechanical ventilation, and cardiac arrest were independent predictors of arrhythmias.

背景:在主要因SARS-CoV-2(COVID-19)住院的人群中,探讨心律失常预测因素的研究很少。了解这一点对于风险分层和适当管理至关重要:我们利用 2020 年全国住院病人样本 (NIS) 数据库,确定了 COVID-19 的主要入院患者。通过 "贪婪的邻居 "1:1倾向得分匹配(PSM)计算基线差异。然后,采用多变量逻辑回归模型来考虑混杂因素并估计心律失常的概率:共有 1,058,815 人因 COVID-19 入院(平均年龄为 64.3 岁 ±16.8 岁),女性占 47.2%,白人占 52.5%(107698 人),黑人占 18.5%(37973 人),西班牙裔占 20.7%(42447 人)。心房颤动是最常见的心律失常,占 15.1%(31942 例)。经过 PSM 后,166,405 例心律失常住院病例与 166,405 例无心律失常住院病例进行了配对。病窦综合征 4.9 (4.4-5.5)、血脂异常 1.2 (1.2-1.3)、心脏骤停 1.3 (1.1-1.4)、有创机械通气 1.9 (1.8-2.0) 和肥胖 1.3 (1.2-1.4),(p 结论:我们的分析显示,住院治疗心律失常的患者比例明显高于无心律失常的患者:我们的分析显示,COVID-19 住院患者中心律失常患者的比例相当高。血脂异常、肥胖、病窦综合征、有创机械通气和心脏骤停是心律失常的独立预测因素。
{"title":"Predictors of arrhythmias in the population hospitalized for SARS-CoV-2","authors":"","doi":"10.1016/j.cpcardiol.2024.102792","DOIUrl":"10.1016/j.cpcardiol.2024.102792","url":null,"abstract":"<div><h3>Background</h3><p>Studies exploring predictors of arrhythmias in the population primarily hospitalized for SARS-CoV-2 (COVID-19) are scarce. Understanding this is crucial for risk stratification and appropriate management.</p></div><div><h3>Methods</h3><p>Using the 2020 National Inpatient Sample (NIS) database, we identified primary admissions for COVID-19. A ‘greedy neighbor’ 1:1 propensity-score matching (PSM) accounted for baseline differences. Then, multivariable logistic regression models were employed to account for confounders and estimate the probability of arrhythmia.</p></div><div><h3>Results</h3><p>There were a total of 1,058,815 admissions for COVID-19 (mean age 64.3 years ±16.8), 47.2% female, 52.5% (107698) White, 18.5% (37973) Blacks, and 20.7% (42,447) Hispanics. Atrial fibrillation was the most prevalent arrhythmia, 15.1% (31,942). After PSM, 166,405 arrhythmia hospitalizations were matched to 166,405 hospitalizations without arrhythmia. Sick sinus syndrome 4.9 (4.4-5.5), dyslipidemia 1.2 (1.2–1.3), cardiac arrest 1.3 (1.1-1.4), invasive mechanical ventilation 1.9 (1.8-2.0) and obesity 1.3 (1.2-1.4), (p&lt;0.0001, all) were all independent predictors of arrhythmias.</p></div><div><h3>Conclusions</h3><p>Our analysis revealed a notable proportion of hospitalized COVID-19 patients with arrhythmias. Dyslipidemia, obesity, sick sinus syndrome, invasive mechanical ventilation, and cardiac arrest were independent predictors of arrhythmias.</p></div>","PeriodicalId":51006,"journal":{"name":"Current Problems in Cardiology","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-08-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141977187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of foot massage on selected physiological parameters among patients with acute coronary syndrome 足部按摩对急性冠状动脉综合征患者部分生理参数的影响
IF 3 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-08-11 DOI: 10.1016/j.cpcardiol.2024.102780

Background

Acute coronary syndrome characterizes the spectrum of myocardial ischemia states, which include non-ST elevated myocardial infarction (MI), and angina.

Objective

The aim of the present study is to determine the effectiveness of foot massage on selected physiological parameters among patients with acute coronary syndrome.

Methods

A quasi- experimental study was conducted in Karbala center for cardiac diseases and surgery from December 25th, 2023, to May 7th, 2024. A nonprobability purposive sampling consisted of 60 patients with acute coronary syndrome in the intervention group were instructed to performed four-step foot massage similarly 5 min for each foot. While patients in the control group just received routine medical treatment. The physiological parameters were checked in the two groups before, after 5 min, and 10 min after the foot massage. The study instrument consisted of two main parts: part one included patient's socio demographics and clinical data, and the second part was used to assess the physiological parameters. Statistical tests were conducted using the software SPSS, version 24, with a level of significance of 5 % (p value <0.05).

Results

that are a significant statistical differences between the mean of the selected physiological parameters readings for the study group except reading of pulse pressure, while there is no significant statistical difference between the mean of the readings of the selected physiological parameters for the control group except the reading of heart rate.

Conclusion

The study found that the foot massage is effective for improving the blood pressure, heart rate, mean arterial pressure.

背景:急性冠状动脉综合征是一系列心肌缺血状态的特征,其中包括非ST段抬高的心肌梗死(MI)和心绞痛:本研究旨在确定足部按摩对急性冠状动脉综合征患者某些生理参数的影响:从 2023 年 12 月 25 日至 2024 年 5 月 7 日,在卡尔巴拉心脏病和外科中心进行了一项准实验研究。干预组的 60 名急性冠状动脉综合征患者在非概率有目的抽样中被指导进行四步足部按摩,每只脚类似地按摩 5 分钟。对照组患者只接受常规治疗。分别在足部按摩前、5 分钟后和 10 分钟后检查两组患者的生理指标。研究工具包括两个主要部分:第一部分包括患者的社会人口统计学和临床数据,第二部分用于评估生理参数。研究使用 SPSS 24 版软件进行统计测试,显著性水平为 5%(P 值<0.05):研究发现,足底按摩能有效改善血压、心率和平均动脉压。
{"title":"Effectiveness of foot massage on selected physiological parameters among patients with acute coronary syndrome","authors":"","doi":"10.1016/j.cpcardiol.2024.102780","DOIUrl":"10.1016/j.cpcardiol.2024.102780","url":null,"abstract":"<div><h3>Background</h3><p>Acute coronary syndrome characterizes the spectrum of myocardial ischemia states, which include non-ST elevated myocardial infarction (MI), and angina.</p></div><div><h3>Objective</h3><p>The aim of the present study is to determine the effectiveness of foot massage on selected physiological parameters among patients with acute coronary syndrome.</p></div><div><h3>Methods</h3><p>A quasi- experimental study was conducted in Karbala center for cardiac diseases and surgery from December 25th, 2023, to May 7th, 2024. A nonprobability purposive sampling consisted of 60 patients with acute coronary syndrome in the intervention group were instructed to performed four-step foot massage similarly 5 min for each foot. While patients in the control group just received routine medical treatment. The physiological parameters were checked in the two groups before, after 5 min, and 10 min after the foot massage. The study instrument consisted of two main parts: part one included patient's socio demographics and clinical data, and the second part was used to assess the physiological parameters. Statistical tests were conducted using the software SPSS, version 24, with a level of significance of 5 % (<em>p</em> value &lt;0.05).</p></div><div><h3>Results</h3><p>that are a significant statistical differences between the mean of the selected physiological parameters readings for the study group except reading of pulse pressure, while there is no significant statistical difference between the mean of the readings of the selected physiological parameters for the control group except the reading of heart rate.</p></div><div><h3>Conclusion</h3><p>The study found that the foot massage is effective for improving the blood pressure, heart rate, mean arterial pressure.</p></div>","PeriodicalId":51006,"journal":{"name":"Current Problems in Cardiology","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-08-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141977186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What happened to the left ventricular non-compaction cardiomyopathy? to be or not to be: This is the question 左心室非充盈性心肌病是怎么回事?是或不是:这是一个问题。
IF 3 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-08-11 DOI: 10.1016/j.cpcardiol.2024.102787

For several years, left ventricular non-compaction (LVNC) was considered as a true cardiomyopathy and several definitions have followed one another.

Particularly, LVNC was characterized by prominent left ventricular trabeculae separated from deep intertrabecular recesses. Several echocardiographic criteria and cardiac magnetic resonance imaging (CMR) criteria have been used to diagnose LVNC, leading to overestimate the diagnosis of LVNC in patients with other diseases and/or physiological conditions.

Left ventricular hypertrabeculation (LVH) can be present in several cardiac diseases and physiological conditions: heart failure with reduced ejection fraction, thalassemia and other hematological diseases, pregnancy, athlete's heart. Thus, the presence of LVH does not necessarily indicate the presence of an LVNC.

In addition, the great heterogeneity of clinical manifestations has raised concerns regarding the existence of a true LVNC as a cardiomyopathy. In fact, LVNC ranges from genetic to acquired and even transient conditions, isolated forms or forms associated with other cardiomyopathies, congenital heart diseases or syndromes with a very different prognosis.

Thus, considering LVH as a manifestation of various diseases and physiological conditions, the recent 2023 ESC guidelines on cardiomyopathies did not include LVNC among cardiomyopathies, but they suggested using the term “LVH” rather than LVNC, to describe this phenotype especially when it is transient or of adult-onset.

In this review, we aimed to make an excursion on LVNC, from its initial description to the present day, to understand why current guidelines decided to consider LVH as a phenotypic trait rather than a distinct cardiomyopathy.

数年来,左心室不充盈(LVNC)一直被认为是一种真正的心肌病,并且有多种定义相继出现。特别是,LVNC 的特征是突出的左心室小梁与深层小梁间凹陷分离。一些超声心动图标准和心脏磁共振成像(CMR)标准被用于诊断 LVNC,导致患有其他疾病和/或生理状况的患者被高估了 LVNC 的诊断。左心室肥厚(LVH)可出现在多种心脏疾病和生理状况中:射血分数降低的心力衰竭、地中海贫血和其他血液病、妊娠、运动员心脏。因此,LVH 的存在并不一定意味着 LVNC 的存在。此外,临床表现的巨大异质性也引起了人们对是否存在真正的 LVNC 心肌病的担忧。事实上,LVNC 的表现形式多种多样,既有遗传性的,也有后天获得性的,甚至还有一过性的,既有孤立的,也有与其他心肌病、先天性心脏病或预后大相径庭的综合征相关的表现形式。因此,考虑到 LVH 是各种疾病和生理状况的一种表现形式,最近的 2023 年 ESC 心肌病指南并未将 LVNC 纳入心肌病,但建议使用 "LVH "而非 LVNC 来描述这种表型,尤其是一过性或成人发病的 LVH。在这篇综述中,我们旨在对 LVNC 从最初的描述到今天的发展进行梳理,以了解为什么目前的指南决定将 LVH 视为一种表型特征,而不是一种独特的心肌病。
{"title":"What happened to the left ventricular non-compaction cardiomyopathy? to be or not to be: This is the question","authors":"","doi":"10.1016/j.cpcardiol.2024.102787","DOIUrl":"10.1016/j.cpcardiol.2024.102787","url":null,"abstract":"<div><p>For several years, left ventricular non-compaction (LVNC) was considered as a true cardiomyopathy and several definitions have followed one another.</p><p>Particularly, LVNC was characterized by prominent left ventricular trabeculae separated from deep intertrabecular recesses. Several echocardiographic criteria and cardiac magnetic resonance imaging (CMR) criteria have been used to diagnose LVNC, leading to overestimate the diagnosis of LVNC in patients with other diseases and/or physiological conditions.</p><p>Left ventricular hypertrabeculation (LVH) can be present in several cardiac diseases and physiological conditions: heart failure with reduced ejection fraction, thalassemia and other hematological diseases, pregnancy, athlete's heart. Thus, the presence of LVH does not necessarily indicate the presence of an LVNC.</p><p>In addition, the great heterogeneity of clinical manifestations has raised concerns regarding the existence of a true LVNC as a cardiomyopathy. In fact, LVNC ranges from genetic to acquired and even transient conditions, isolated forms or forms associated with other cardiomyopathies, congenital heart diseases or syndromes with a very different prognosis.</p><p>Thus, considering LVH as a manifestation of various diseases and physiological conditions, the recent 2023 ESC guidelines on cardiomyopathies did not include LVNC among cardiomyopathies, but they suggested using the term “LVH” rather than LVNC, to describe this phenotype especially when it is transient or of adult-onset.</p><p>In this review, we aimed to make an excursion on LVNC, from its initial description to the present day, to understand why current guidelines decided to consider LVH as a phenotypic trait rather than a distinct cardiomyopathy.</p></div>","PeriodicalId":51006,"journal":{"name":"Current Problems in Cardiology","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-08-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141977188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of preoperative breathing exercises on postoperative lung function outcomes for patients with cardiac surgery 术前呼吸练习对心脏手术患者术后肺功能结果的影响
IF 3 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-08-10 DOI: 10.1016/j.cpcardiol.2024.102784
{"title":"Effectiveness of preoperative breathing exercises on postoperative lung function outcomes for patients with cardiac surgery","authors":"","doi":"10.1016/j.cpcardiol.2024.102784","DOIUrl":"10.1016/j.cpcardiol.2024.102784","url":null,"abstract":"","PeriodicalId":51006,"journal":{"name":"Current Problems in Cardiology","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141972308","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiogenic shock in the context of acute coronary syndromes in Latin America (“LATIN Shock”) 拉丁美洲急性冠状动脉综合征背景下的心源性休克("LATIN 休克")。
IF 3 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-08-10 DOI: 10.1016/j.cpcardiol.2024.102745

Cardiogenic shock (CS) is a serious complication of heart attack and constitutes one of its main causes of death. To date, there is no data on its treatment and evolution in Latin America.

Objectives

To know the clinical characteristics, treatment strategies, evolution and in-hospital mortality of CS in Latin America.

Materials and methods

This is a prospective, multicenter registry of patients hospitalized with CS in the context of acute coronary syndromes (ACS) with and without ST segment elevation for 24 months.

Results

41 Latin American centers participated incorporating patients during the period between October 2021 and September 2023. 278 patients were included. Age: 66 (59-75) years, 70.1 % men. 74.8 % of the cases correspond to ACS with ST elevation, 14.4 % to ACS without ST elevation, 5.7 % to right ventricular infarction and 5.1 % to mechanical complications. CS was present from admission in 60 % of cases. Revascularization: 81.3 %, inotropic use: 97.8 %, ARM: 52.5 %, Swan Ganz: 17 %, intra-aortic balloon pump: 22.2 %. Overall in-hospital mortality was 52.7 %, with no differences between ACS with or without ST.

Conclusions

Morbidity and mortality is very high despite the high reperfusion used.

心源性休克(CS)是心脏病发作的一种严重并发症,也是导致死亡的主要原因之一。迄今为止,拉丁美洲还没有关于其治疗和演变的数据:了解拉丁美洲 CS 的临床特征、治疗策略、演变情况和院内死亡率:这是一项前瞻性多中心登记,对象为急性冠状动脉综合征(ACS)住院患者,包括 ST 段抬高和非 ST 段抬高患者,为期 24 个月:结果:41 个拉丁美洲中心在 2021 年 10 月至 2023 年 9 月期间参与了患者登记。共纳入 278 名患者。年龄:66(59-75)岁,70.1% 为男性。74.8%的病例为ST段抬高的ACS,14.4%为无ST段抬高的ACS,5.7%为右心室梗死,5.1%为机械并发症。60%的病例在入院时就存在CS。血管重建率:81.3%,肌力药物使用率:97.8%,ARM使用率:97.8%:97.8%,ARM:52.5%,Swan Ganz:17%,主动脉内球囊泵:22.2%。院内总死亡率为 52.7%,有 ST 或无 ST 的 ACS 之间没有差异:结论:尽管使用了大量再灌注,但发病率和死亡率仍然很高。
{"title":"Cardiogenic shock in the context of acute coronary syndromes in Latin America (“LATIN Shock”)","authors":"","doi":"10.1016/j.cpcardiol.2024.102745","DOIUrl":"10.1016/j.cpcardiol.2024.102745","url":null,"abstract":"<div><p>Cardiogenic shock (CS) is a serious complication of heart attack and constitutes one of its main causes of death. To date, there is no data on its treatment and evolution in Latin America.</p></div><div><h3>Objectives</h3><p>To know the clinical characteristics, treatment strategies, evolution and in-hospital mortality of CS in Latin America.</p></div><div><h3>Materials and methods</h3><p>This is a prospective, multicenter registry of patients hospitalized with CS in the context of acute coronary syndromes (ACS) with and without ST segment elevation for 24 months.</p></div><div><h3>Results</h3><p>41 Latin American centers participated incorporating patients during the period between October 2021 and September 2023. 278 patients were included. Age: 66 (59-75) years, 70.1 % men. 74.8 % of the cases correspond to ACS with ST elevation, 14.4 % to ACS without ST elevation, 5.7 % to right ventricular infarction and 5.1 % to mechanical complications. CS was present from admission in 60 % of cases. Revascularization: 81.3 %, inotropic use: 97.8 %, ARM: 52.5 %, Swan Ganz: 17 %, intra-aortic balloon pump: 22.2 %. Overall in-hospital mortality was 52.7 %, with no differences between ACS with or without ST.</p></div><div><h3>Conclusions</h3><p>Morbidity and mortality is very high despite the high reperfusion used.</p></div>","PeriodicalId":51006,"journal":{"name":"Current Problems in Cardiology","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141917992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Empowering treatment decisions: ChatGPT in severe coronary artery disease 赋予治疗决策权:严重冠状动脉疾病的 ChatGPT。
IF 3 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-08-10 DOI: 10.1016/j.cpcardiol.2024.102789
{"title":"Empowering treatment decisions: ChatGPT in severe coronary artery disease","authors":"","doi":"10.1016/j.cpcardiol.2024.102789","DOIUrl":"10.1016/j.cpcardiol.2024.102789","url":null,"abstract":"","PeriodicalId":51006,"journal":{"name":"Current Problems in Cardiology","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141972309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current Problems in Cardiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1